Fingerprint
Dive into the research topics of '18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
18F-FDG PET/CT for Monitoring Response of Merkel Cell Carcinoma to the Novel Programmed Cell Death Ligand 1 Inhibitor Avelumab
Naghmehossadat Eshghi*, Tamara F. Lundeen, Lea Mackinnon, Ryan Avery, Phillip H. Kuo
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations